David Schmidt and a Look at Clinical Trials

We often hear about the results of clinical trials and how they have the potential to change our approach to health and wellness. However, this information can lose its impact if a person is not familiar with what clinical trials truly are and why they are the gold standard for gathering scientific health information. To further explore the topic, we’ve taken time to provide an overview of the work of David Schmidt at LifeWave, the health and wellness company that he founded

What Is a Clinical Trial?

At its core, a clinical trial is a research study that is conducted to answer a specific question about a new health and wellness therapy or product. These studies can help researchers analyze a wide range of potential therapies, such as vaccines, drugs, operative procedures, or new product technologies to improve disabling conditions. These trials do more than determine whether a potential therapy is effective; they also test the safety of the therapy and help determine its efficacy compared to other similar therapies or products that are already available. If it appears that, say, a product is both safe and effective, it may be moved to new phases, where additional effects can be studied or the product can be tested on a larger scale.

Clinical trials are at the heart of the work conducted by David Schmidt at LifeWave. His company’s patented phototherapy technology is based on an appreciation for the widespread use of light for achieving therapeutic outcomes. However, the company could not just base its efforts on the theoretical concepts that underpin its work; it needed to test the efficacy of its products as well. That’s one of the reasons that LifeWave has placed a high priority on clinical tests for any new product that it releases. It not only helps confirm the efficacy of the product, but it also helps build confidence in these innovative technologies.

Moving Through Phases

Clinical studies are often conducted in phases, with each progressive phase having different goals for testing outcomes. Phase I studies are typically kept to a small number of participants and are designed to allow for a first investigation into the effects of a given therapy or product. A term often used for these smaller efforts is “pilot study.” A main focus of these early trials is safety. This ensures that a new product is considered safe for wider use before it is tested with larger groups. This is also a time for scientists to make initial observations about the effects that a product has on test subjects.

Phase II studies are conducted after the initial safety of a product has been established in an earlier phase along with the early results that indicate the product is achieving its intended outcome. This phase typically takes place with a larger group than was used in the first phase. It can be used to further evaluate the effects of the product on users and see how these effects may vary over a large population. In the case of drugs, this phase can also be an opportunity to examine how different therapeutic doses can affect user outcomes and what side-effects are seen. This can include determining the safest and most effective way to dose a therapy so that users can achieve the maximum benefits. 

Phase III studies are often carried out on even larger trial groups and provide researchers with a better idea of how a therapy might perform in the population at large. This may be the last phase of trials before a therapy is made available to the wider market, so it is often an opportunity to give a therapy a final check to make sure that it accomplishes its goals in a safe and effective manner. Trials in this phase can give researchers the best opportunity to see what general use of the therapy will look like and how it will behave once it reaches the market. 

Focus on Studies

In his work with LifeWave, David Schmidt has made it a point to emphasize clinical studies with the technologies that he creates. One of the reasons for this focus is a desire to provide users and selling partners with the greatest amount of information about his company’s products. In the absence of such information, there may be questions regarding the efficacy of the company’s offerings. With study information easily accessible through the company’s website, it’s much more straightforward for sellers and consumers to understand how the products function and the potential positive impacts they could have on their lives.

This is especially relevant when looking at the company’s main product – its patented phototherapy patches. These topically applied patches utilize nanotechnology to reflect specific wavelengths of light back into the user’s body. By placing the patches at specific points along the body, the technology can have a range of positive impacts on users. This can include improved quality of sleep and greater access to energy and stamina.

Studies in Action

One example of the company utilizing clinical studies to benefit its customers occurred during the development of its patented X39 patches. These patches, created over more than 10 years of research and innovation, focus on harnessing the power of the company’s phototherapy methods using patented patches to gently stimulate points on the skin to help maintain the natural flow of energy throughout the body, sustaining the body’s natural healing process tied to healthy and essential stem cell activity. The benefits to the human body include positively impacting minor pain, mental clarity skin appearance, quality and duration of sleep… generally helping to elevate the body’s health and wellness to an optimal level. These discoveries would have been impossible to achieve without LifeWave’s reliance on systematic clinical trials.

While we often hear of clinical trials taking place in connection with new health and wellness therapies and products, many individuals lack a basic understanding of what these trials truly are. Here, we’ve provided a first look at what these trials are and how they progress through disparate phases to achieve an end goal. The efforts of David Schmidt at LifeWave provide an excellent example of this work in practice. A look at those efforts can help you better understand how health and wellness companies continue to innovate on behalf of their customers and the broader population.